三种降脂药物与记忆丧失之间的关联:现实世界药监测研究
Jingyi Chen1,2, Yang Wu1,2, Yan Liu1,2
1Department of Neurology, Affiliated Hospital of Nanjing University of Chinese Medicine, 155 Hanzhong Road, Nanjing, 210029, People's Republic of China.
Naunyn-Schmiedeberg's archives of pharmacology
|January 22, 2026
概括
研究人员分析了与失忆症相关的不良事件,包括他类药物,PCSK9抑制剂和ezetimibe. 类他类药物显示出最强的关联,而埃泽胺对记忆障碍有相反的关联,大多数事件发生在治疗早期.
科学领域:
- 药物监督 药物监督 药物监督
- 神经科学是一个神经科学.
- 药品安全 药品安全
背景情况:
- 药物不良反应,包括像失忆症这样的认知效应,是一个重大问题.
- 类药物,PCSK9抑制剂和ezetimibe是常用的降脂疗法,安全性概况各不相同.
- 了解与这些药物类别相关的记忆丧失的具体风险对于临床实践至关重要.
研究的目的:
- 为了比较他类药物,PCSK9抑制剂和ezetimibe与失忆症相关的不良事件之间的关联.
- 通过使用现实世界的数据,分析这些协会的信号强度和模式.
- 为了研究药物开始和记忆丧失的开始之间的时间关系.
主要方法:
- 美国食品和药物管理局不良事件报告系统 (FAERS) 从2004年第一季度到2025年第一季度的数据的回顾性分析.
- 不成比例分析 (报告几率比率) 以检测不良事件信号.
- 时间到发病分析,以评估不良事件发生的时间.
- 后勤回归用于调整混因素并比较信号强度.
主要成果:
- 对于六种记忆丧失相关不良事件中的五种,他类药物表现出了积极信号.
- PCSK9抑制剂显示出对记忆障碍的积极信号 (ROR=1.50).
- 埃泽提米布显示出对失忆症的积极信号 (ROR=1.55) 但对记忆障碍的反向关联 (ROR=0.50).
- 根据调整后,他类药物对记忆丧失和记忆障碍的信号强度显著更强,而不是以泽提米布.
- 大多数与失忆症相关的不良事件发生在治疗过程的早期.
结论:
- 在研究的降脂药物中,他类药物对与失忆症相关的不良事件提供了最强烈的信号.
- PCSK9抑制剂具有相对较低的信号,而埃泽可能与某些失忆症亚型有相反的关联.
- 大多数事件的早期发作表明潜在的时间依赖模式,需要进一步调查因果关系.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Vapor Pressure Lowering
30.7K
The equilibrium vapor pressure of a liquid is the pressure exerted by its gaseous phase when vaporization and condensation are occurring at equal rates:
30.7K
Amnesia
478
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
478
Dissociative Amnesia
554
Dissociative amnesia is a complex psychological condition that manifests as an inability to recall personal information, often tied to traumatic or stressful events. Unlike general amnesia, individuals with this condition retain the ability to perform routine activities and procedural tasks, such as operating a phone or navigating public transportation, yet experience profound gaps in autobiographical memory. These lapses may encompass significant life events, such as suicide attempts or...
554
Genome-wide Association Studies-GWAS
15.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.4K


